CNTG
Centogene NV

985
Mkt Cap
$3.1M
Volume
4,090.00
52W High
$0.705
52W Low
$0.0003
Price
$0.1061
CNTG Fundamentals
Prev Close
$0.1068
Open
$0.1061
50D MA
$0.1023
Beta
-1.10
Avg. Volume
140.53
Loading...
Loading...
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Centogene NV?
What is the 52-week high for Centogene NV?
What is the 52-week low for Centogene NV?
What is Centogene NV stock price today?
What was Centogene NV stock price yesterday?
What is the 50-day moving average of Centogene NV?

Latest CNTG News

View
No CNTG news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.